Romero-González JP

Idioma: Español
Referencias bibliográficas: 10
Paginas: 288-289
Archivo PDF: 126.08 Kb.

FRAGMENTO

La carcinomatosis peritoneal es una complicación oncológica grave asociada a la presencia de tumores malignos en ovario, estómago, colon y recto, y tiene como característica tumores con resección quirúrgica limitada y de mal pronóstico. El tratamiento convencional consiste en la realización de paracentesis evacuadoras y la administración de quimioterapia endovenosa; sin embargo, su margen terapéutico es limitado. Hoy en día, la combinación de ciru

REFERENCIAS (EN ESTE ARTÍCULO)

1. Bell JC, Rylah BG, Chambers RW, Peet H, Mohamed F, Moran BJ. Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience. Ann Surg Oncol. 2012;19:4244-4251.

2. Chua TC, Robertson G, Liauw W, Farrell R, Yan TD, Morris DL. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results. J Cancer Res Clin Oncol. 2009;135:1637-1645.

3. Al-Shammaa HA, Li Y. Current status and future strategies of cytorreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. World J Gastroenterol. 2008;14:1159-1166.

4. Yonemura Y, Bandou E. Quantitative prognostic indicators of peritoneal dissemination of gastric cancer. Eur J Surg Oncol. 2006;32:602-606.

5. Chua TC, Yan TD. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg. 2009;249:900-907.

6. Arakelian E, Torkzad MR, Bergman A, Rubertsson S, Mahteme H. Pulmonary influences on early postoperative recovery in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: a retrospective study. World J Surg Oncol. 2012;10:258.

7. Cooksley TJ, Haji-Michael P. Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). World J Surg Oncol. 2011;9:169.

8. Schmidt C, Creutzenberg M, Piso P, Hobbhahn J, Bucher M. Perioperative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia. 2008;63:389-395.

9. Piso P, Schmidt C, Wiesenack C, Bucher M, Schlitt HJ, Graf BM. Particularities of anesthesia and postoperative intensive care related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [Internet]. Timisoara. 2009 [Citado el 2014 Feb]; 815-820. Disponible en: http://www.atitimisoara.ro/_fi les/documents/files/2009/Actualitati%20ATI%20si%20Medicina%20de%20Urgenta%202009/Particularities%20of%20anesthesia%20and%20postoperative%20intensive%20care%20related%20to%20cytoreductive%20surgery%20a. Pdf

10. Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patient selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:5.